SOLX EUROPE LTD

Profile

Company Names

SOLX EUROPE LTD

Addresses

6 HENRIETTA STREET, C/O MVM LIFE SCIENCE FUND, LONDON, X0 WC2E 8PU

Phone Numbers

617 383 2102

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

UNITED KINGDOM

Total Amount Raised:

$2,250,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-08-27 
$2,250,000.00 
$10,999,063.00 
$8,749,063.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NEIL 
 
AKHURST 
DIRECTOR
SOLX INC   |  SOLX EUROPE LTD
ERIC 
 
BEDNARSKI 
DIRECTOR
TARSA THERAPEUTICS, INC.   |  AMPLA PHARMACEUTICALS INC   |  SOLX INC   |  PREXA PHARMACEUTICALS INC   |  ACCUVEIN INC.   |  MVM IV LP   |  SOLX EUROPE LTD   |  BIOTHERANOSTICS, INC.   |  VERO BIOTECH INC.   |  NEUROLENS, INC.   |  MDXHEALTH SA   |  MVM VI LP   |  OPTINOSE, INC.   |  MVM J LP
FRANK 
 
FLAUTT 
DIRECTOR
SOLX INC   |  SOLX EUROPE LTD
BOSUN 
 
HAU 
DIRECTOR
SOLX INC   |  VASCULAR PATHWAYS INC   |  AMBIO HOLDINGS, INC.   |  SOLX EUROPE LTD   |  ALPHAEON CORP   |  ELCELYX THERAPEUTICS, INC.   |  ZELEGENT, INC.   |  WUGEN, INC.
JIM 
 
LARGENT 
DIRECTOR
TEARSCIENCE, INC.   |  SOLX INC   |  SOLX EUROPE LTD
KEVIN 
 
MCMAHON 
EXECUTIVE OFFICER, DIRECTOR
SOLX INC   |  SOLX EUROPE LTD   |  AQUASMART ENTERPRISES, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-09-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-08-27 
2015-09-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-08-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#